Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
Chang Lin
Joan-En
JE
Welty
Devin
D
D000287:Administration, Topical; D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism; D001372:Aza Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001682:Biological Availability; D003320:Corneal Ulcer / Q000188:drug therapy / Q000378:metabolism* / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000378:metabolism* / Q000382:microbiology; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D009883:Ophthalmic Solutions / Q000008:administration & dosage / Q000493:pharmacokinetics; D011804:Quinolines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013666:Tears / Q000378:metabolism; D014822:Vitreous Body / Q000378:metabolism
D001372:Aza Compounds; D024841:Fluoroquinolones; D009883:Ophthalmic Solutions; D011804:Quinolines; D000077266:Moxifloxacin